Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq

Expert Review of Molecular Diagnostics
Scott V BratmanMaximilian Diehn

Abstract

Tumors continually shed DNA into the circulation, where it can be noninvasively accessed. The ability to accurately detect circulating tumor DNA (ctDNA) could significantly impact the management of patients with nearly every cancer type. Quantitation of ctDNA could allow objective response assessment, detection of minimal residual disease and noninvasive tumor genotyping. The latter application overcomes the barriers currently limiting repeated tumor tissue sampling during therapy. Recent technical advancements have improved upon the sensitivity, specificity and feasibility of ctDNA detection and promise to enable innovative clinical applications. Here, we focus on the potential clinical utility of ctDNA analysis using CAncer Personalized Profiling by deep Sequencing (CAPP-Seq), a novel next-generation sequencing-based approach for ultrasensitive ctDNA detection. Applications of CAPP-Seq for the personalization of cancer detection and therapy are discussed.

Associated Clinical Trials

References

Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A CastellsA Farré
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·B Vogelstein, K W Kinzler
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D SeidmanC A Hudis
Aug 2, 2008·Nature Medicine·Frank DiehlLuis A Diaz
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea FerrariLuigi Mariani
Apr 29, 2010·JAMA : the Journal of the American Medical Association·Michaela A DinanKevin A Schulman
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ParkPeter McL Black
May 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Isaac KindeBert Vogelstein
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Oct 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuya TaniguchiKikuya Kato
Dec 24, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Xiaojian WuPing Lan
Feb 7, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kitty HuangDavid A Palma
Apr 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A PunnooseMark R Lackner
May 23, 2012·JAMA : the Journal of the American Medical Association·Peter B BachFrank C Detterbeck
Jun 1, 2012·Science Translational Medicine·Tim ForshewNitzan Rosenfeld
Aug 17, 2012·The New England Journal of Medicine·Eveline A M HeijnsdijkHarry J de Koning
Dec 1, 2012·Science Translational Medicine·Rebecca J LearyVictor E Velculescu
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
Apr 19, 2013·Nature Reviews. Genetics·Leslie G Biesecker, Nancy B Spinner
Sep 3, 2013·Nature Methods·Christopher M HindsonMuneesh Tewari
Jan 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey R OxnardPasi A Jänne
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis A Diaz, Alberto Bardelli
Feb 21, 2014·Science Translational Medicine·Chetan BettegowdaLuis A Diaz

❮ Previous
Next ❯

Citations

Jun 24, 2016·The Breast : Official Journal of the European Society of Mastology·G CuriglianoS A Hurvitz
Feb 2, 2017·International Journal of Molecular Sciences·Julie A VendrellJérôme Solassol
Dec 3, 2017·Scientific Reports·Nidal MuhannaScott V Bratman
Sep 6, 2018·Biology of Reproduction·Aymara Mas, Carlos Simón
Jan 17, 2019·Expert Review of Molecular Diagnostics·Claire FranczakAlexandre Harlé
Oct 28, 2018·Cellular Oncology (Dordrecht)·Heidi FettkeArun A Azad
Apr 19, 2017·Proceedings of the National Academy of Sciences of the United States of America·Austin K MattoxNickolas Papadopoulos
Jan 27, 2017·International Journal of Cancer. Journal International Du Cancer·Xin YiXuefeng Xia
Mar 29, 2016·Nature Biotechnology·Aaron M NewmanAsh A Alizadeh
Nov 11, 2016·Science Translational Medicine·Florian SchererAsh A Alizadeh
Oct 1, 2016·Chonnam Medical Journal·Fariz NurwidyaFaisal Yunus
Dec 7, 2018·Bioinformatics·Chang Sik KimCrispin Miller
Dec 28, 2018·NPJ Precision Oncology·Erin R BonnerJavad Nazarian
Aug 9, 2016·Analytical and Bioanalytical Chemistry·Noemi Bellassai, Giuseppe Spoto
Mar 7, 2020·Scientific Reports·So Ngo LamChun Kin Chow
Oct 6, 2017·Journal of Separation Science·Vladimíra DatinskáFrantišek Foret
Jul 2, 2017·Cancer Metastasis Reviews·Preeti Kanikarla-MarieScott Kopetz
Apr 4, 2019·Molecular Diagnosis & Therapy·Re-I ChinAadel A Chaudhuri
Sep 26, 2020·Journal of Hematology & Oncology·Dayoung JungMichael Wang
Oct 6, 2018·Journal of Diabetes and Metabolic Disorders·Fatemeh Khatami, Seyed Mohammad Tavangar
Oct 10, 2020·World Journal of Clinical Oncology·Gliceida Maria Galarza Fortuna, Kathrin Dvir
Jul 3, 2021·Pharmaceuticals·Elodie BohersFabrice Jardin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Related Papers

Clinical Advances in Hematology & Oncology : H&O
Michiaki Kubo
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Tobias M GorgesOliver von Ahsen
© 2021 Meta ULC. All rights reserved